Monday, 19 October 20267:35 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

Health

Implantable cardioverter-defibrillators may benefit certain younger patients with mild-moderate heart dysfunction: JAMA

Image: Business Medical Dialogues. Rights remain with the publisher.

An implantable cardioverter-defibrillator did not improve the primary endpoint overall in the CMR GUIDE trial but younger patients appeared to benefit, according to results presented in a Hot Line...

Read the full report on Business Medical Dialogues

Story file

Section
Health
First reported by
Business Medical Dialogues
Reporter
dr. kamal kant kohli
Published
Monday, 19 October 2026, 6:01 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Business Medical Dialogues with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More Health news

See all